Alex Azar Nominated as HHS Secretary

Pauline Gross
November 14, 2017

Azar's nomination comes a little more than a month after the resignation of HHS Secretary Tom Price.

On Nov. 13, President Trump nominated Alex Azar as secretary of Health and Human Services, a role that was vacated after Tom Price resigned in late September after it was reported that he spent $1 million of taxpayers' dollars on private air travel while on the job.

Azar, who now works for a consulting firm, worked as the HHS general counsel from 2001 to 2005 in the George W. Bush administration.

Aznar served in the George W. Bush White House on the domestic policy council and at HHS is a a former president of drug giant Eli Lilly.

More Sunshine, Warmer Monday
Wednesday: The clouds will return on Wednesday along with a 60 percent chance for rain in the afternoon and evening hours. FRIDAY NIGHT/SATURDAY: Models indicate a more dynamic system towards the end of the week, but differ slightly on timing.

IPhone X Plus with even larger OLED screen tipped for 2018
While no one has an idea on how the iPhone X can go even bigger, a visualized render of the iPhone X Plus has surfaced recently. Earlier this month the auto correct issue emerged when people updated their phones to version 11.1 of the iOS operating system.

Chinese shoppers spend a record $38.2bn during Singles' Day shopping festival
While that's only half the growth rate a year ago , the event still dwarfs others such as Black Friday and Cyber Monday. Jack Ma , the Chinese teacher-turned-business tycoon founded the Alibaba in 1999.

If confirmed, Azar will oversee large parts of the federal government's healthcare, including the U.S. Food & Drug Administration (FDA), which has begun regulating cigars. He's seen as an expert on government health care regulation. In an October letter to Trump, Sens.

In making the pick, Trump turned to an industry's he's rebuked.

Azar's nominations to HHS in the Bush era sailed through the Senate. "I am. interested in how, given Mr. Azar's professional background, he believes he can fairly execute any significant effort to lower drug prices for patients", she said in a statement. "The drug companies, frankly, are getting away with murder", the president said at a Cabinet meeting this fall. Prices are "out of control" and "have gone through the roof", Trump said. In meetings with industry executives, however, Trump has focused on speeding up drug approvals, a cost-reducing tactic they would back.

Other reports by GizPress

Discuss This Article